These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 35379215)
1. Retention on antiretroviral therapy in person with HIV and viral hepatitis coinfection in Ethiopia: a retrospective cohort study. Seyoum E; Demissie M; Worku A; Mihret A; Abdissa A; Berhane Y BMC Public Health; 2022 Apr; 22(1):644. PubMed ID: 35379215 [TBL] [Abstract][Full Text] [Related]
2. Modeling the impact of early antiretroviral therapy for adults coinfected with HIV and hepatitis B or C in South Africa. Martin NK; Devine A; Eaton JW; Miners A; Hallett TB; Foster GR; Dore GJ; Easterbrook PJ; Legood R; Vickerman P AIDS; 2014 Jan; 28 Suppl 1():S35-46. PubMed ID: 24468945 [TBL] [Abstract][Full Text] [Related]
3. Increased risk of hip fracture associated with dually treated HIV/hepatitis B virus coinfection. Byrne DD; Newcomb CW; Carbonari DM; Nezamzadeh MS; Leidl KB; Herlim M; Yang YX; Hennessy S; Kostman JR; Leonard MB; Localio AR; Lo Re V J Viral Hepat; 2015 Nov; 22(11):936-47. PubMed ID: 25754215 [TBL] [Abstract][Full Text] [Related]
4. HIV, hepatitis B virus, and hepatitis C virus co-infection among HIV positives in antiretroviral treatment program in selected hospitals in Addis Ababa: A retrospective cross-sectional study. Seyoum E; Demissie M; Worku A; Mulu A; Abdissa A; Berhane Y PLoS One; 2022; 17(4):e0267230. PubMed ID: 35452472 [TBL] [Abstract][Full Text] [Related]
5. Higher Mortality Despite Early Antiretroviral Therapy in Human Immunodeficiency Virus and Hepatitis B Virus (HBV)-Coinfected Patients With High HBV Replication. Kouamé GM; Boyd A; Moh R; Badje A; Gabillard D; Ouattara E; Ntakpe JB; Emième A; Maylin S; Chekaraou MA; Eholié SP; Zoulim F; Lacombe K; Anglaret X; Danel C; Clin Infect Dis; 2018 Jan; 66(1):112-120. PubMed ID: 29020361 [TBL] [Abstract][Full Text] [Related]
6. Risk of hip fracture associated with hepatitis C virus infection and hepatitis C/human immunodeficiency virus coinfection. Lo Re V; Volk J; Newcomb CW; Yang YX; Freeman CP; Hennessy S; Kostman JR; Tebas P; Leonard MB; Localio AR Hepatology; 2012 Nov; 56(5):1688-98. PubMed ID: 22619086 [TBL] [Abstract][Full Text] [Related]
7. Clinical Characteristics and Treatment Outcomes of Patients with Hepatitis C Virus and Human Immunodeficiency Virus Coinfection: Experience at a Single Center in Korea. Lim DH; Jeong JY; Nam S; Choi J; Kwon HC; Yoon YB; Kim Y; Chin B J Korean Med Sci; 2021 Nov; 36(46):e308. PubMed ID: 34845874 [TBL] [Abstract][Full Text] [Related]
8. Differential predictors of ART adherence among HIV-monoinfected versus HIV/HCV-coinfected individuals. Shuper PA; Joharchi N; Irving H; Fletcher D; Kovacs C; Loutfy M; Walmsley SL; Wong DK; Rehm J AIDS Care; 2016 Aug; 28(8):954-62. PubMed ID: 26971360 [TBL] [Abstract][Full Text] [Related]
9. Risk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individuals. Gillis J; Smieja M; Cescon A; Rourke SB; Burchell AN; Cooper C; Raboud JM; Antivir Ther; 2014; 19(3):309-17. PubMed ID: 24429380 [TBL] [Abstract][Full Text] [Related]
10. Modelling CD4 T Cell Recovery in Hepatitis C and HIV Co-infected Children Receiving Antiretroviral Therapy. Majekodunmi AO; Thorne C; Malyuta R; Volokha A; Callard RE; Klein NJ; Lewis J; Pediatr Infect Dis J; 2017 May; 36(5):e123-e129. PubMed ID: 28403051 [TBL] [Abstract][Full Text] [Related]
11. HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes. Benhammou V; Tubiana R; Matheron S; Sellier P; Mandelbrot L; Chenadec JL; Marel E; Khoshnood B; Warszawski J; J Acquir Immune Defic Syndr; 2018 Apr; 77(5):439-450. PubMed ID: 29287028 [TBL] [Abstract][Full Text] [Related]
12. Brief Report: Increased Inflammation and Liver Disease in HIV/HBV-Coinfected Individuals. Copeland NK; Eller MA; Kim D; Creegan M; Esber A; Eller LA; Semwogerere M; Kibuuka H; Kiweewa F; Crowell TA; Polyak CS; Ake JA J Acquir Immune Defic Syndr; 2021 Nov; 88(3):310-313. PubMed ID: 34267057 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B and C viral coinfections and their association with HIV viral load suppression among HIV-1 infected patients on ART at Mekelle hospital, northern Ethiopia. Teame G; Gebreyesus A; Tsegay E; Gebretsadik M; Adane K AIDS Res Ther; 2022 Dec; 19(1):57. PubMed ID: 36457041 [TBL] [Abstract][Full Text] [Related]
14. Treatment outcomes of HIV patients with hepatitis B and C virus co-infections in Southwest China: an observational cohort study. Jia J; Zhu Q; Deng L; Lan G; Johnson A; Chen H; Shen Z; Li J; Xing H; Ruan Y; Li J; Lu H; Vermund SH; Zhu J; Qian HZ Infect Dis Poverty; 2022 Jan; 11(1):7. PubMed ID: 34986877 [TBL] [Abstract][Full Text] [Related]
15. Risk of End-Stage Liver Disease in HIV-Viral Hepatitis Coinfected Persons in North America From the Early to Modern Antiretroviral Therapy Eras. Klein MB; Althoff KN; Jing Y; Lau B; Kitahata M; Lo Re V; Kirk GD; Hull M; Kim HN; Sebastiani G; Moodie EE; Silverberg MJ; Sterling TR; Thorne JE; Cescon A; Napravnik S; Eron J; Gill MJ; Justice A; Peters MG; Goedert JJ; Mayor A; Thio CL; Cachay ER; Moore R; ; Clin Infect Dis; 2016 Nov; 63(9):1160-1167. PubMed ID: 27506682 [TBL] [Abstract][Full Text] [Related]
16. Hepatitis delta is a major determinant of liver decompensation events and death in HIV-infected patients. Fernández-Montero JV; Vispo E; Barreiro P; Sierra-Enguita R; de Mendoza C; Labarga P; Soriano V Clin Infect Dis; 2014 Jun; 58(11):1549-53. PubMed ID: 24633686 [TBL] [Abstract][Full Text] [Related]
17. Opportunistic disease and mortality in patients coinfected with hepatitis B or C virus in the strategic management of antiretroviral therapy (SMART) study. Tedaldi E; Peters L; Neuhaus J; Puoti M; Rockstroh J; Klein MB; Dore GJ; Mocroft A; Soriano V; Clotet B; Lundgren JD; Clin Infect Dis; 2008 Dec; 47(11):1468-75. PubMed ID: 18959492 [TBL] [Abstract][Full Text] [Related]
18. Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort. Quaranta MG; Ferrigno L; Tata X; D'Angelo F; Coppola C; Ciancio A; Bruno SR; Loi M; Giorgini A; Margotti M; Cossiga V; Brancaccio G; Dallio M; De Siena M; Cannizzaro M; Cavalletto L; Massari M; Mazzitelli M; De Leo P; Laccabue D; Baiocchi L; Kondili LA BMC Infect Dis; 2021 May; 21(1):413. PubMed ID: 33947337 [TBL] [Abstract][Full Text] [Related]
19. The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. Pol S; Haour G; Fontaine H; Dorival C; Petrov-Sanchez V; Bourliere M; Capeau J; Carrieri P; Larrey D; Larsen C; Marcellin P; Pawlostky JM; Nahon P; Zoulim F; Cacoub P; de Ledinghen V; Mathurin P; Negro F; Pageaux GP; Yazdanpanah Y; Wittkop L; Zarski JP; Carrat F; Aliment Pharmacol Ther; 2017 Dec; 46(11-12):1054-1060. PubMed ID: 28994127 [TBL] [Abstract][Full Text] [Related]